Real-time quaking-induced conversion

References

• Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363 - 13383
   PubMed Web of Science ®Google Scholar
• Hamaguchi T, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Sato T, Kitamoto T, et al. The risk of iatrogenic Creutzfeldt-Jakob disease through medical and surgical procedures. Neuropathology 2009; 29:625 - 631
   Google Scholar
• Ironside JW. Variant Creutzfeldt-Jakob disease. Haemophilia 5:175 - 180
   Google Scholar
• Castilla J, Saa P, Morales R, Abid K, Maundrell K, Soto C. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol 2006; 412:3 - 21
   PubMed Web of Science ®Google Scholar
• Atarashi R. Recent advances in cell-free PrPSc amplification technique. Protein Pept Lett 2009; 16:256 - 259
   PubMed Web of Science ®Google Scholar
• Saa P, Castilla J, Soto C. Presymptomatic detection of prions in blood. Science 2006; 313:92 - 94
   PubMed Web of Science ®Google Scholar
• Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, Onwubiko HA, et al. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 2007; 4:645 - 650
   PubMed Web of Science ®Google Scholar
• Colby DW, Zhang Q, Wang S, Groth D, Legname G, Riesner D, et al. Prion detection by an amyloid seeding assay. Proc Natl Acad Sci USA 2007; 104:20914 - 20919
   PubMed Web of Science ®Google Scholar
• Atarashi R, Wilham JM, Christensen L, Hughson AG, Moore RA, Johnson LM, et al. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods 2008; 5:211 - 212
   PubMed Web of Science ®Google Scholar
• Orru CD, Wilham JM, Hughson AG, Raymond LD, McNally KL, Bossers A, et al. Human variant Creutzfeldt-Jakob disease and sheep scrapie PrP(res) detection using seeded conversion of recombinant prion protein. Protein Eng Des Sel 2009; 22:515 - 521
   PubMed Web of Science ®Google Scholar
• Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, et al. Cell-free formation of protease-resistant prion protein. Nature 1994; 370:471 - 474
   PubMed Web of Science ®Google Scholar
• Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 2011; 17:175 - 178
   PubMed Web of Science ®Google Scholar
• Toth SI, Smith LA, Ahmed SA. Extreme sensitivity of botulinum neurotoxin domains towards mild agitation. J Pharm Sci 2009; 98:3302 - 3311
   PubMed Web of Science ®Google Scholar
• Collins SR, Douglass A, Vale RD, Weissman JS. Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLoS Biol 2004; 2:321
   PubMed Web of Science ®Google Scholar
• Lansbury P Jr, Caughey B. The chemistry of scrapie infection: implications of the ‘ice 9’ metaphor. Chem Biol 1995; 2:1 - 5
   PubMed Web of Science ®Google Scholar
• Sluzky V, Tamada JA, Klibanov AM, Langer R. Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc Natl Acad Sci USA 1991; 88:9377 - 9381
   PubMed Web of Science ®Google Scholar
• Treuheit MJ, Kosky AA, Brems DN. Inverse relationship of protein concentration and aggregation. Pharm Res 2002; 19:511 - 516
   PubMed Web of Science ®Google Scholar
• Caughey B, Kocisko DA, Raymond GJ, Lansbury P Jr. Aggregates of scrapie-associated prion protein induce the cell-free conversion of protease-sensitive prion protein to the protease-resistant state. Chem Biol 1995; 2:807 - 817
   PubMed Web of Science ®Google Scholar
• Baskakov IV, Bocharova OV. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features. Biochemistry 2005; 44:2339 - 2348
   PubMedGoogle Scholar
• Jain S, Udgaonkar JB. Evidence for stepwise formation of amyloid fibrils by the mouse prion protein. J Mol Biol 2008; 382:1228 - 1241
   PubMed Web of Science ®Google Scholar
• Stohr J, Weinmann N, Wille H, Kaimann T, Nagel-Steger L, Birkmann E, et al. Mechanisms of prion protein assembly into amyloid. Proc Natl Acad Sci USA 2008; 105:2409 - 2414
   PubMed Web of Science ®Google Scholar
• Horiuchi M, Caughey B. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J 1999; 18:3193 - 3203
   PubMed Web of Science ®Google Scholar
• Nishina K, Jenks S, Supattapone S. Ionic strength and transition metals control PrPSc protease resistance and conversion-inducing activity. J Biol Chem 2004; 279:40788 - 40794
   PubMed Web of Science ®Google Scholar
• Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46:224 - 233
   PubMed Web of Science ®Google Scholar
• Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996; 335:924 - 930
   PubMed Web of Science ®Google Scholar
• Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998; 43:32 - 40
   PubMed Web of Science ®Google Scholar
• Satoh K, Tobiume M, Matsui Y, Mutsukura K, Nishida N, Shiga Y, et al. Establishment of a standard 14-3-3 protein assay of cerebrospinal fluid as a diagnostic tool for Creutzfeldt-Jakob disease. Lab Invest 2010; 90:1637 - 1644
   PubMed Web of Science ®Google Scholar
• Orru CD, Wilham JM, Raymond LD, Kuhn F, Schroeder B, Raeber AJ, et al. Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. MBio 2011; 2:00078-11
   Web of Science ®Google Scholar
• Wilham JM, Orru CD, Bessen RA, Atarashi R, Sano K, Race B, et al. Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog 2011; 6:1001217
   Web of Science ®Google Scholar